ARTICLE | Clinical News
Androderm testosterone regulatory update
October 31, 2011 7:00 AM UTC
FDA approved 2 and 4 mg doses of transdermal Androderm testosterone for daily use as testosterone replacement therapy in males for conditions associated with a deficiency or absence of endogenous test...